Fig. 2

Relationship between year-to-year trends in concomitant use duration of triple anti-thrombotic therapy and bleeding events. a) Trends in duration of concomitant use of triple anti-thrombotic therapy by year of PCI. b) Relationship between duration of concomitant use of triple anti-thrombotic therapy and bleeding. Duration of concomitant use of triple antithrombotic therapy was collected at the end of follow-up. PCI, percutaneous coronary intervention